Business Standard

Tuesday, December 24, 2024 | 09:41 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Bal Pharma reports standalone net loss of Rs 4.14 crore in the March 2020 quarter

Image

Capital Market

Sales decline 39.92% to Rs 33.77 crore

Net loss of Bal Pharma reported to Rs 4.14 crore in the quarter ended March 2020 as against net profit of Rs 3.57 crore during the previous quarter ended March 2019. Sales declined 39.92% to Rs 33.77 crore in the quarter ended March 2020 as against Rs 56.21 crore during the previous quarter ended March 2019.

For the full year,net loss reported to Rs 9.53 crore in the year ended March 2020 as against net profit of Rs 6.76 crore during the previous year ended March 2019. Sales declined 23.49% to Rs 170.67 crore in the year ended March 2020 as against Rs 223.08 crore during the previous year ended March 2019.

 
ParticularsQuarter EndedYear EndedMar. 2020Mar. 2019% Var.Mar. 2020Mar. 2019% Var.Sales33.7756.21 -40 170.67223.08 -23 OPM %2.3411.87 -3.679.10 - PBDT-0.583.84 PL -2.5410.53 PL PBT-3.611.47 PL -9.574.41 PL NP-4.143.57 PL -9.536.76 PL

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 30 2020 | 8:52 AM IST

Explore News